High level of ROS was usually proposed as the cell-damaging factors of chemotherapy [19], while sustained and moderate production of ROS in MDR cells exhibited signal effects to activate survival signaling pathways such as the PI3K/Akt pathway, which facilitates oncogenic phenotype of cancer [20, 21]. The gene discussed is AKT1; the disease is cancer.